Class Action Lawsuit Filed Against Charming Medical
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1h ago
0mins
Source: Globenewswire
- Lawsuit Background: Bragar Eagel & Squire, P.C. has filed a class action lawsuit against Charming Medical in the Southern District of New York on behalf of investors who purchased shares between October 10 and November 12, 2025, aiming to protect investor rights and seek compensation.
- Allegation Details: The complaint alleges that Charming failed to disclose that its stock price was artificially inflated due to fraudulent social media promotions, and insiders used offshore accounts to facilitate stock dumping, resulting in investor losses.
- Stock Price Volatility: During the class period, Charming's stock surged from an IPO price of $4.00 to a high of $29.36, despite no fundamental news justifying such an increase, indicating potential market manipulation.
- Trading Suspension: On November 12, 2025, the SEC halted trading of Charming's stock, which remains suspended as the company has not provided the required information to regulators, exacerbating investor anxiety and potential losses.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
